ANN D RHOADS
CIK 1250252 · Chief Financial Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.58M
Companies
10
Total Filings
87
Lifetime Open-Market Net
-$2.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Director | 40,384 | $80.39 | $3.25M | -$3.05M | 22 | 2026-06-08 |
| QDEL | Director | 23,257 | $14.13 | $328.6K | $21.2K | 19 | 2026-06-02 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 0 | $2.65 | $0 | $80.0K | 7 | 2026-01-28 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | — | $10.15 | — | $0 | 7 | 2025-08-29 |
| Evoke Pharma Inc (EVOK) Delisted | Director | — | $11.00 | — | $0 | 3 | 2021-07-23 |
| Forty Seven, Inc. (FTSV) Delisted | Chief Financial Officer | 0 | — | — | -$183.6K | 3 | 2020-04-07 |
| IRIX | Director | 5,690 | $1.12 | $6.4K | $0 | 3 | 2018-06-15 |
| Evoke Pharma Inc (OMED) Delisted | Director | — | — | — | $0 | 5 | 2018-04-27 |
| ZOGENIX, INC. (ZGNX) Delisted | EVP, CFO, Treasurer & Sec. | 199,209 | $26.68 | $5.31M | $220.8K | 11 | 2016-03-16 |
| NOVELLUS SYSTEMS INC (NVLS) Delisted | Director | 35,000 | — | — | $0 | 5 | 2011-05-13 |
Recent Filings · Page 8 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-01-27 | GMED | Grant (A) | — | $0 | EDGAR |
| 2013-09-26 | Evoke Pharma Inc (OMED) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-09-05 | GMED | Grant (A) | — | $0 | EDGAR |
| 2013-06-20 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | +46,000 | $0 | EDGAR |
| 2013-03-15 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-12 | ZOGENIX, INC. (ZGNX) Delisted | Buy (P) | +17,500 | $20.8K | EDGAR |
| 2012-08-10 | GMED | Other (J) | — | $0 | EDGAR |
| 2012-06-06 | — | Disp (D) | −35,000 | $0 | |
| 2012-04-30 | ZOGENIX, INC. (ZGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-09-21 | ZOGENIX, INC. (ZGNX) Delisted | Buy (P) | +100,000 | $200.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.